Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXP1275 in mild-to-moderate atopic asthma
NCT01890161Phase 2Completed
- Sponsor
- Axikin Pharmaceuticals, Inc.
- Start
- Aug 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AXP1275, sponsored by Axikin Pharmaceuticals, Inc.. Started Aug 2013; status: completed.
02
Drugs
AXP1275
Beyond the preview
Go deeper on NCT01890161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01890161.